ST PHARM was founded in 1983 and has been providing cGMP-compliant services from the drug development stage to commercialization for pharmaceutical companies worldwide. Over the decades, it has earned recognition for its quality and services from pharmaceutical companies globally, establishing itself as a CDMO (Contract Development and Manufacturing Organization) with specialized expertise in process development and large-scale production optimization.

With a strong reputation in the industry, ST PHARM has positioned itself as a global partner for the development of new drugs, spanning from small molecules to advanced RNA-based compounds such as Oligonucleotides and mRNA. As an innovative company committed to saving lives, it seeks to grow together with its partners, contributing to advancements in the field of life-saving medicines.